News Our expertise Patents FAQs Trademarks FAQs Industrial Designs FAQs Litigation FAQS Selection achievements
Kirill Osipov commented on the recent invalidation of yet another patent of Russian generic producer Nativa February 11, 2019 Pharmaceutical Bulletin – one of the largest professional magazines devoted to Russian pharma – published an article on the recent invalidation of yet another patent of Nativa. Nativa is a Russian generic producer, infamous for its involvement in numerous patent infringement cases with the largest originator makers. Nativa’s patent, rendered invalid in the end of January, was for invention claimed to be dependent on the substance patented by Bristol-Myers Squibb and used in the production of Sprycel. The Head of Legal Department of ARS-Patent Kirill Osipov provided his comments to Pharmaceutical Bulletin on the case and the acute problem of dependent inventions in general. The full article is available here. Make an enquiry
Latest News Reimbursement of expenses when considering the disputes in Rospatent2024-02-21In accordance with the new Federal Law No. 390361-8 of January 30, 2024, with proposed amendments to Article 1248 of the Civil Code of the Russian Fed...Read moreAmendments and addenda to the Patent Regulations under the EAPC2024-01-12As of January 1, 2024, amendments and addenda to Part I «Inventions» and Part II «Industrial Designs» of the Patent Regulations to the Eurasian Pa...Read moreView all our NewsMEET WITH US Meet ARS-Patent at the 2023 AIPPI World Congress2023-09-26The 2023 AIPPI World Congress will bring together up to 2000 intellectual property professionals from around the world for a prestigious event, which ...Read more2023 IPO Annual Meeting2023-08-16We are glad to announce that Pavel Vorobev, the Client Manager and Patent Attorney of ARS-Patent, will attend the 2023 Intellectual Property Owners As...Read moreSee all Events
Reimbursement of expenses when considering the disputes in Rospatent2024-02-21In accordance with the new Federal Law No. 390361-8 of January 30, 2024, with proposed amendments to Article 1248 of the Civil Code of the Russian Fed...Read more
Amendments and addenda to the Patent Regulations under the EAPC2024-01-12As of January 1, 2024, amendments and addenda to Part I «Inventions» and Part II «Industrial Designs» of the Patent Regulations to the Eurasian Pa...Read more
Meet ARS-Patent at the 2023 AIPPI World Congress2023-09-26The 2023 AIPPI World Congress will bring together up to 2000 intellectual property professionals from around the world for a prestigious event, which ...Read more
2023 IPO Annual Meeting2023-08-16We are glad to announce that Pavel Vorobev, the Client Manager and Patent Attorney of ARS-Patent, will attend the 2023 Intellectual Property Owners As...Read more